Multidisciplinary Association for Psychedelic Studies

Ecstasy for the Terminally Ill? Will This Party Drug Prove Effective Against Anxiety?

Medicine & Technology May 28, 2015

Scientists from the Multidisciplinary Association for Psychedelic Studies (MAPS) are hoping to help 18 terminally ill patients relieve their anxiety, depression, and fear in the next year during extended psychotherapy sessions enhanced by MDMA (ecstasy). The Marin County-based double-blind trial will see subjects test either full doses of MDMA (125 milligrams) or active placebo doses (30 milligrams).

Most Popular

How Technology Is Changing the Real Estate Industry?

How a Plant-Based Diet Can Protect Against Breast Cancer: Insights from Nutrition Research

How a Plant-Based Diet Can Protect Against Breast Cancer: Insights from Nutrition Research

Study Reveals High Turnover in Scientific Research Careers: What This Means for Future Scientists

Nikolay Karpenko – Founder of Herculis Group

Nikolay Karpenko Biography, Photo, Career, Accomplishments

Why It's So Difficult to Lose Weight: The Biological Explanation Behind Obesity

Recommended Stories

NASA Shuts Down Voyager 2 Science Instrument After 47 Years to Conserve Power

SPACE

NASA Shuts Down Voyager 2 Science Instrument After 47 Years to Conserve Energy

OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find “Hallucinated” Text in Transcripts

TECH & INNOVATION

OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts

Martian Ice May Support Microbial Life Beneath Its Surface, New Study Suggests

SPACE

Martian Ice May Support Microbial Life Beneath Its Surface, New Study Suggests

NASA Astronaut Hospitalized After Returning from Extended Space Mission

SPACE

NASA Astronaut Hospitalized After Returning from Extended Space Mission